Large intergenic non-coding RNA-ROR reverses Gemcitabine-induced autophagy and apoptosis in breast cancer cells

被引:47
作者
Chen, Yao-Min [1 ]
Liu, Yu [1 ]
Wei, Hai-Yan [1 ]
Lv, Ke-Zhen [1 ]
Fu, Pei-Fen [1 ]
机构
[1] Zhejiang Univ, Dept Breast Surg, Affiliated Hosp 1, Hangzhou 310000, Zhejiang, Peoples R China
关键词
breast cancer; linc-ROR; gemcitabine; large intergenic non-coding; PANCREATIC-CANCER; GENE-EXPRESSION; STEM-CELLS; THERAPY; PATHWAY; DIFFERENTIATION; CONTRIBUTES; BEVACIZUMAB; METASTASIS; INHIBITION;
D O I
10.18632/oncotarget.10730
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to elucidate the potential role of long intergenic non-protein coding RNA, regulator of reprogramming (linc-ROR) in gemcitabine (Gem)-induced autophagy and apoptosis in breast cancer cells. MDA-MB-231 cells were treated with short hairpin RNA (shRNA) to knockdown Linc-ROR expression in the presence of Gem. Gem treatment alone decreased cell survival and increased both apoptosis and autophagy. Gem treatment also increased the expression of LC3-II, Beclin 1, NOTCH1 and Bcl-2, but decreased expression of p62 and p53. Untreated MDA-MB-231 cell lines strongly expressed linc-ROR, but linc-ROR knockdown decreased cell viability and expression of p62 and p53 while increasing apoptosis. Linc-ROR knockdown also increased LC3-II/beta-actin, Beclin 1, NOTCH1, and Bcl-2 expression, as well as the number of autophagic vesicles in MDA-MB-231 cells. Linc-ROR negatively regulated miR-34a expression by inhibiting histone H3 acetylation in the miR-34a promoter. We conclude that linc-ROR suppresses Gem-induced autophagy and apoptosis in breast cancer cells by silencing miR-34a expression.
引用
收藏
页码:59604 / 59617
页数:14
相关论文
共 54 条
[1]  
Amaral JD, 2010, DISCOV MED, V9, P145
[2]  
[Anonymous], TUMOUR BIOL
[3]  
Askarian-Amiri ME, 2016, METHODS MOL BIOL, V1395, P207, DOI 10.1007/978-1-4939-3347-1_12
[4]   p53-dependent Induction of PVT1 and miR-1204 [J].
Barsotti, Anthony M. ;
Beckerman, Rachel ;
Laptenko, Oleg ;
Huppi, Konrad ;
Caplen, Natasha J. ;
Prives, Carol .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) :2509-2519
[5]   Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer [J].
Bear, Harry D. ;
Tang, Gong ;
Rastogi, Priya ;
Geyer, Charles E., Jr. ;
Robidoux, Andre ;
Atkins, James N. ;
Baez-Diaz, Luis ;
Brufsky, Adam M. ;
Mehta, Rita S. ;
Fehrenbacher, Louis ;
Young, James A. ;
Senecal, Francis M. ;
Gaur, Rakesh ;
Margolese, Richard G. ;
Adams, Paul T. ;
Gross, Howard M. ;
Costantino, Joseph P. ;
Swain, Sandra M. ;
Mamounas, Eleftherios P. ;
Wolmark, Norman .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) :310-320
[6]  
Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]
[7]   Defining the membrane precursor supporting the nucleation of the phagophore [J].
Bernard, Amelie ;
Klionsky, Daniel J. .
AUTOPHAGY, 2014, 10 (01) :1-2
[8]   Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis [J].
Chang, Tsung-Cheng ;
Wentzel, Erik A. ;
Kent, Oliver A. ;
Ramachandran, Kalyani ;
Mullendore, Michael ;
Lee, Kwang Hyuck ;
Feldmann, Georg ;
Yamakuchi, Munekazu ;
Ferlito, Marcella ;
Lowenstein, Charles J. ;
Arking, Dan E. ;
Beer, Michael A. ;
Maitra, Anirban ;
Mendell, Joshua T. .
MOLECULAR CELL, 2007, 26 (05) :745-752
[9]   Regulation of the autophagy protein LC3 by phosphorylation [J].
Cherra, Salvatore J., III ;
Kulich, Scott M. ;
Uechi, Guy ;
Balasubramani, Manimalha ;
Mountzouris, John ;
Day, Billy W. ;
Chu, Charleen T. .
JOURNAL OF CELL BIOLOGY, 2010, 190 (04) :533-539
[10]   ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy [J].
Dewaele, Michael ;
Maes, Hannelore ;
Agostinis, Patrizia .
AUTOPHAGY, 2010, 6 (07) :838-854